Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
BrevaRex (AR20.5)
i
Other names:
AR20.5, mAb AR20.5, mAb-AR20.5, MAbAR20.5
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
CanariaBio, Quest PharmaTech
Drug class:
MUC1 inhibitor
Related drugs:
‹
gatipotuzumab (5)
BTH1704 (0)
ETBX-061 (0)
GO-203-2c (0)
GT-00A x IL15 (0)
VXL100 (0)
ONT-10 (0)
PDC*lung (0)
falimarev/inalimarev (0)
tecemotide (0)
Undisclosed MUC1 peptide-poly-ICLC adjuvant vaccine (0)
activated CIK and bispecific antibody (0)
activated CIK-anti-CD3/MUC1/CEA/EpCAM/GPC3 antibody (0)
TG4010 (0)
gatipotuzumab (5)
BTH1704 (0)
ETBX-061 (0)
GO-203-2c (0)
GT-00A x IL15 (0)
VXL100 (0)
ONT-10 (0)
PDC*lung (0)
falimarev/inalimarev (0)
tecemotide (0)
Undisclosed MUC1 peptide-poly-ICLC adjuvant vaccine (0)
activated CIK and bispecific antibody (0)
activated CIK-anti-CD3/MUC1/CEA/EpCAM/GPC3 antibody (0)
TG4010 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login